ZA200502926B - 4-Methylhexanoic kahalaide F compound. - Google Patents

4-Methylhexanoic kahalaide F compound.

Info

Publication number
ZA200502926B
ZA200502926B ZA200502926A ZA200502926A ZA200502926B ZA 200502926 B ZA200502926 B ZA 200502926B ZA 200502926 A ZA200502926 A ZA 200502926A ZA 200502926 A ZA200502926 A ZA 200502926A ZA 200502926 B ZA200502926 B ZA 200502926B
Authority
ZA
South Africa
Prior art keywords
kahalaide
methylhexanoic
compound
methylhexanoic kahalaide
Prior art date
Application number
ZA200502926A
Other languages
English (en)
Inventor
Glynn Thomas Faircloth
Halina Sasak
Maria Del Carmen Cue Marchante
Mariano Aviles Marin Pa Elices
Original Assignee
Pharma Mar Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2002/004735 external-priority patent/WO2003033012A1/en
Priority claimed from GBGB0304367.6A external-priority patent/GB0304367D0/en
Priority claimed from GB0314725A external-priority patent/GB0314725D0/en
Application filed by Pharma Mar Sau filed Critical Pharma Mar Sau
Publication of ZA200502926B publication Critical patent/ZA200502926B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
ZA200502926A 2002-10-18 2005-04-11 4-Methylhexanoic kahalaide F compound. ZA200502926B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2002/004735 WO2003033012A1 (en) 2001-10-19 2002-10-18 Kahalalide compounds for use in cancer therapy
GBGB0304367.6A GB0304367D0 (en) 2003-02-26 2003-02-26 Methods for treating psoriasis
GB0314725A GB0314725D0 (en) 2003-06-24 2003-06-24 New antitumoral compounds

Publications (1)

Publication Number Publication Date
ZA200502926B true ZA200502926B (en) 2006-02-22

Family

ID=32110555

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200502926A ZA200502926B (en) 2002-10-18 2005-04-11 4-Methylhexanoic kahalaide F compound.

Country Status (10)

Country Link
EP (1) EP1572726B1 (xx)
JP (1) JP4430009B2 (xx)
CN (2) CN101077885A (xx)
BR (1) BR0315489A (xx)
CA (1) CA2501089C (xx)
ES (1) ES2357644T3 (xx)
MX (1) MXPA05004133A (xx)
NZ (1) NZ539093A (xx)
WO (1) WO2004035613A2 (xx)
ZA (1) ZA200502926B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
GB0304367D0 (en) 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
WO2009052379A2 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
DE102008005097B4 (de) * 2008-01-18 2011-04-07 Leibnitz-Institut für Meereswissenschaften Antitumoraler Cyclodepsipeptide, deren Herstellung und Verwendung
KR20100126479A (ko) * 2008-03-07 2010-12-01 파르마 마르 에스.에이. 개선된 항종양 치료법들
WO2009135939A2 (en) * 2008-05-09 2009-11-12 Pharma Mar, S.A. Depsipeptide for use in cancer therapy
CA2817420C (en) 2010-11-12 2019-09-24 Pharma Mar, S.A. Combination therapy with an antitumor alkaloid
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9302046D0 (en) * 1993-02-03 1993-03-24 Pharma Mar Sa Antiumoral compound-v
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
SK286421B6 (sk) * 2000-10-31 2008-09-05 Pharma Mar, S. A. Prostriedok kahalalid F, súprava, rekonštituovanýa zriedený roztok s obsahom tohto prostriedku a použitie
EP1435990A1 (en) * 2001-10-19 2004-07-14 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy

Also Published As

Publication number Publication date
WO2004035613A2 (en) 2004-04-29
ES2357644T3 (es) 2011-04-28
CN100591691C (zh) 2010-02-24
NZ539093A (en) 2007-10-26
WO2004035613A3 (en) 2004-07-29
MXPA05004133A (es) 2005-10-05
CA2501089A1 (en) 2004-04-29
EP1572726A2 (en) 2005-09-14
BR0315489A (pt) 2005-08-23
JP2006517195A (ja) 2006-07-20
CN101077885A (zh) 2007-11-28
EP1572726B1 (en) 2010-12-08
CN1705677A (zh) 2005-12-07
CA2501089C (en) 2012-07-17
JP4430009B2 (ja) 2010-03-10

Similar Documents

Publication Publication Date Title
GB0229015D0 (en) New Compound
EP1558585A4 (en) NEUROLOGICALLY ACTIVE COMPOUNDS
GB0225548D0 (en) Compounds
ZA200502926B (en) 4-Methylhexanoic kahalaide F compound.
GB0200283D0 (en) Compounds
PL397821A1 (pl) Związek1-acetylo-6-fluoro-2-indolinon
ZA200408738B (en) Organic compounds.
GB0204241D0 (en) Compound
AU2003216859A8 (en) Amidoacetonitrile compounds
GB0224830D0 (en) Compound
GB0216383D0 (en) Compounds
GB0203778D0 (en) Compounds
GB0213027D0 (en) Compound
AU2003275480A8 (en) Compounds
GB0203811D0 (en) Compounds
ZA200407363B (en) Novel compounds.
GB0206981D0 (en) Compounds
TW578950U (en) Compound type functional foot-frame
GB0217506D0 (en) Compound
GB0229576D0 (en) Compound
GB0229075D0 (en) Compound
GB0209274D0 (en) Compound
GB0213014D0 (en) Compound
GB0214267D0 (en) Compound
ZA200408338B (en) Heterocyclic compounds.